Product Details
METHYLPREDNISOLONE 4 MG TAB 21
Manufacturer: ZYDUS PHARMACEUTICALS USA INC
MFG#: 68382-0916-34
NDC: 68382-0916-34
PID: 653501
UN
$ *.**
In StockAdditional Information
| Product Name | Methylprednisolone 4 Mg Tab 21 |
| Application | Anti-inflammatory, Immunosuppressant |
| Active Ingredient | Methylprednisolone |
| Mechanism of Action | Inhibits inflammatory cytokines, suppresses immune response |
| Dosage Form | Tablet |
| Strength | 4 mg |
| Administration Route | Oral |
| Onset of Action | 1-2 hours |
| Duration of Action | 18-36 hours |
| Adverse Effects | Hypertension, hyperglycemia, osteoporosis, fluid retention |
| Precautions | Monitor blood glucose, bone density, infection risk |
| Tapering Requirement | Yes, to prevent adrenal insufficiency |
| Pregnancy Category | C (Risk not ruled out, use if necessary) |
| Storage Conditions | Store at controlled room temperature, protect from moisture |
| Packaging | 21 tablets |
| Indications | Allergic reactions, asthma, arthritis, autoimmune diseases |
Description
Methylprednisolone 4 mg tablets are synthetic glucocorticoids used for their anti-inflammatory and immunosuppressive properties. They modulate gene expression to inhibit pro-inflammatory cytokines and suppress immune responses. This medication is indicated for a wide range of conditions, including allergic reactions, autoimmune diseases, respiratory disorders, and inflammatory conditions such as arthritis.
Each tablet contains 4 mg of methylprednisolone and is typically prescribed in tapering doses over a defined period. The standard regimen often includes a 21-tablet pack to follow a structured dosage reduction schedule. This approach minimizes withdrawal effects and ensures controlled suppression of inflammation.
Adverse effects include fluid retention, hypertension, hyperglycemia, osteoporosis, gastrointestinal irritation, and immunosuppression. Long-term use requires monitoring for adrenal suppression and metabolic disturbances. Patients with infections, diabetes, peptic ulcers, or osteoporosis require careful assessment before initiation.
Product Properties:
| Description | N |
|---|---|
| Description | N |
| DESI Drug Ind | -; - |
| DESI Drug Ind | -; - |
| Drug Category | USES: Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders. |
| Drug Category | USES: Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders. |
| Drug Type Code | COMMON BRAND NAME(S): Medrol |
| Drug Type Code | COMMON BRAND NAME(S): Medrol |
| HCPCS | 1 |
| HCPCS | 1 |
| Medical Coverage | - |
| Medical Coverage | - |
| Termination Date | (METH-il-pred-NIS-oh-lone) |
| Termination Date | (METH-il-pred-NIS-oh-lone) |
| Active Ingredients | 2160 methylprednisolone 83432 |
| Active Ingredients | 2160 methylprednisolone 83432 |
| AHFS Class | 68040000 ADRENALS |
| AHFS Class | 68040000 ADRENALS |
| DEA Class | NC |
| DEA Class | NC |
| Dose Form | TABLET, DOSE PACK |
| Dose Form | TABLET, DOSE PACK |
| Fine Line Class | 850085008510 All Rx Products |
| Fine Line Class | 850085008510 All Rx Products |
| Gen Code and Des | 45311 methylprednisolone ORAL TAB DS PK 4 MG |
| Gen Code and Des | 45311 methylprednisolone ORAL TAB DS PK 4 MG |
| Inactive Ingredients | 2432 lactose 64044515 |
| Inactive Ingredients | 2432 lactose 64044515 |
| OMP Family | - |
| OMP Family | - |
| Product Category | RX Pharmaceuticals |
| Product Category | RX Pharmaceuticals |
| Strength | 4MG |
| Strength | 4MG |
| Common Brand Name | J7509 |
| Common Brand Name | J7509 |
| Drug Interaction | - |
| Drug Interaction | - |
| Allocation Period | - |
| Allocation Period | - |
| Case Quantity | 104 |
| Case Quantity | 104 |
| Drug Form Pack Size | 21 |
| Drug Form Pack Size | 21 |
| Form | TABLET |
| Form | TABLET |
| Hazard Code | - |
| Hazard Code | - |
| Listed Chemical | - |
| Listed Chemical | - |
| NIOSH Code | - |
| NIOSH Code | - |
| Orange Book | AB Products meeting necessary bioequivalence requirements. |
| Orange Book | AB Products meeting necessary bioequivalence requirements. |
| Retail Pack Quantity | 1 |
| Retail Pack Quantity | 1 |
| Returnable Status | Returnable |
| Returnable Status | Returnable |
| Special Storage Cond | 00 None |
| Special Storage Cond | 00 None |
| Temp Zone | 10 Room Temperature |
| Temp Zone | 10 Room Temperature |
| Unit | EA |
| Unit | EA |
| Unit Size | 21 |
| Unit Size | 21 |
| How to Use | - |
| How to Use | - |
| Missed Dose | 1 |
| Missed Dose | 1 |
| Notes | TAB |
| Notes | TAB |
| Overdose | AB |
| Overdose | AB |
| Phonetic Pronunciation | COVERED WITH SPECIAL INSTRUCTIONS |
| Phonetic Pronunciation | COVERED WITH SPECIAL INSTRUCTIONS |
| Precautions | - |
| Precautions | - |
| Side Effects | - |
| Side Effects | - |
| Storage | 04/23/2018 |
| Storage | 04/23/2018 |
| Uses | Methylprednisolone oral, 4 MG |
| Uses | Methylprednisolone oral, 4 MG |
Frequently Asked Questions (FAQs)
The cost of METHYLPREDNISOLONE 4 MG TAB 21 is $$0.00
METHYLPREDNISOLONE 4 MG TAB 21 is manufactured by ZYDUS PHARMACEUTICALS USA INC.
You can purchase METHYLPREDNISOLONE 4 MG TAB 21 on our website at https://supplies.pipelinemedical.com/product/detail/methylprednisolone-4-mg-tab-21-305942